These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 19323943)

  • 1. Maximizing benefit of drug-eluting stent by direct coronary stenting because of further reduction of inflammatory response.
    Li JJ; Gao RL
    Chin Med J (Engl); 2009 Mar; 122(6):732-5. PubMed ID: 19323943
    [No Abstract]   [Full Text] [Related]  

  • 2. Late in-stent restenosis in a patient with drug-eluting stent.
    Sultan FA; Kazmi K; Dhakam S; Quraishi AU
    J Coll Physicians Surg Pak; 2005 Oct; 15(10):648-9. PubMed ID: 19810309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular brachytherapy revisited for in-stent restenosis in the drug-eluting stent era: current status and future perspective.
    Li XJ; Rha SW; Wani SP; Wang L; Poddar KL; Oh DJ
    Chin Med J (Engl); 2009 Sep; 122(18):2174-9. PubMed ID: 19781306
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-restenosis study on a new drug eluting stent].
    Zhao A; Zhang H; Huang N; Zhang B; Yang K; Li Z; Zhao H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):856-9, 878. PubMed ID: 18788296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stents: a comprehensive appraisal.
    Butt M; Connolly D; Lip GY
    Future Cardiol; 2009 Mar; 5(2):141-57. PubMed ID: 19371189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bifurcation stenting: current strategies and new devices.
    Latib A; Colombo A; Sangiorgi GM
    Heart; 2009 Mar; 95(6):495-504. PubMed ID: 18812408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory response, drug-eluting stent and restenosis.
    Li JJ
    Chin Med J (Engl); 2008 Mar; 121(6):566-72. PubMed ID: 18364149
    [No Abstract]   [Full Text] [Related]  

  • 9. [Balloon angioplasty for the treatment of the drug-eluting stent restenosis in a patient with multivessel coronary artery disease and muscular bridge].
    Pawłowski T; Kulawik T; Rzezak J
    Kardiol Pol; 2008 Nov; 66(11):1229-31; discussion 1232. PubMed ID: 19105104
    [No Abstract]   [Full Text] [Related]  

  • 10. Bifurcation coronary artery disease: current techniques and future directions (part 2).
    Rizik DG; Klassen KJ; Hermiller JB
    J Invasive Cardiol; 2008 Mar; 20(3):135-41. PubMed ID: 18316830
    [No Abstract]   [Full Text] [Related]  

  • 11. Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era?
    Jimenez-Valero S; Moreno R; Sanchez-Recalde A; Galeote G; Calvo L; Viana A; Lopez de Sá E; López-Sendón J
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):137-46. PubMed ID: 19124417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting stents to transform cardiovascular medicine.
    Morrow T
    Manag Care; 2003 Jul; 12(7):47-50. PubMed ID: 12891955
    [No Abstract]   [Full Text] [Related]  

  • 13. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery restenosis: a paradigm of current treatment approaches.
    Kiernan TJ; Kiernan GD; Yan BD
    Minerva Cardioangiol; 2009 Feb; 57(1):77-94. PubMed ID: 19202520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrepide; Trapidil eluting stent.
    Khan M; Mhulláin FN; Nolan M
    EuroIntervention; 2008 Nov; 4(3):405-11. PubMed ID: 19110816
    [No Abstract]   [Full Text] [Related]  

  • 16. Which is the most appropriate stenting technique with drug-eluting stent for unprotected left main bifurcation stenosis?
    Park SJ
    Catheter Cardiovasc Interv; 2008 Feb; 71(2):173-4. PubMed ID: 18327833
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of restenosis: is angioplasty the answer?
    Scheller B; Speck U; Böhm M
    Heart; 2007 May; 93(5):539-41. PubMed ID: 17435062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The high cost of nonadherence after percutaneous coronary intervention--can health care reform solve this problem?
    Mukherjee D
    Am Heart J; 2009 Oct; 158(4):506-8. PubMed ID: 19781406
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of patients with in-stent restenosis.
    Alfonso F; Pérez-Vizcayno MJ; Cruz A; García J; Jimenez-Quevedo P; Escaned J; Hernandez R
    EuroIntervention; 2009 May; 5 Suppl D():D70-8. PubMed ID: 19736076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of long-term outcomes of bare metal or drug-eluting stent implantation in standard versus off-label coronary narrowings.
    Harjai KJ; Orshaw P; Boura J; Sporn D
    Am J Cardiol; 2009 Jun; 103(11):1537-45. PubMed ID: 19463512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.